About EyeYon
EyeYon is a company based in Ness Ziona (Israel) founded in 2011 by Nahum Ferera.. EyeYon has raised $35.1 million across 3 funding rounds from investors including GF Securities, BPC Banking Tech and Quark Venture. EyeYon offers products and services including EndoArt® and Hyper-CL™. EyeYon operates in a competitive market with competitors including CorneaGen, Avedro, EyeGate, Cellusion and CorNeat Vision, among others.
- Headquarter Ness Ziona, Israel
- Founders Nahum Ferera
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$35.1 M (USD)
in 3 rounds
-
Latest Funding Round
$25 M (USD), Series C
Mar 15, 2021
-
Investors
GF Securities
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EyeYon
EyeYon offers a comprehensive portfolio of products and services, including EndoArt® and Hyper-CL™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthetic implant to treat corneal edema and replace donor tissues.
Contact lens that enhances bioavailability of topical eye drops for conditions.
Unlock access to complete
Funding Insights of EyeYon
EyeYon has successfully raised a total of $35.1M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $25.0M
-
First Round
First Round
(21 Apr 2015)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series C - EyeYon | Valuation |
investors |
|
| Mar, 2017 | Amount | Series A - EyeYon | Valuation | Rimonci | |
| Apr, 2015 | Amount | Series A - EyeYon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EyeYon
EyeYon has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include GF Securities, BPC Banking Tech and Quark Venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused early stage VC firm investing in North America
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early stage healthcare startups
|
Founded Year | Domain | Location | |
|
Limited information is provided about Rimonci's activities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EyeYon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EyeYon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eyeyon Comparisons
Competitors of EyeYon
EyeYon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, Avedro, EyeGate, Cellusion and CorNeat Vision, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic devices for corneal transplants are developed by CorneaGen.
|
|
| domain | founded_year | HQ Location |
Corneal collagen cross-linking technology is developed for ophthalmic applications.
|
|
| domain | founded_year | HQ Location |
Therapeutics and drug delivery systems for eye diseases are developed.
|
|
| domain | founded_year | HQ Location |
iPS cell-based technology for corneal endothelium regeneration is developed.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eyeyon
Frequently Asked Questions about EyeYon
When was EyeYon founded?
EyeYon was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Where is EyeYon located?
EyeYon is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Who is the current CEO of EyeYon?
Nahum Ferera is the current CEO of EyeYon. They have also founded this company.
Is EyeYon a funded company?
EyeYon is a funded company, having raised a total of $35.1M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.6M, raised on Apr 21, 2015.
What does EyeYon do?
EyeYon was founded in 2011 in Ness Ziona, Israel, and operates in the ophthalmic medical device sector. Therapeutic contact lenses, such as the Hyper-CL, are developed for managing corneal pathologies. Additionally, the EndoArt implant, a polymer film attached to the posterior corneal surface, is created to address corneal edema resulting from endothelial dysfunction. Focus is placed on innovative solutions for eye-related conditions.
Who are the top competitors of EyeYon?
What products or services does EyeYon offer?
EyeYon offers EndoArt® and Hyper-CL™.
Who are EyeYon's investors?
EyeYon has 8 investors. Key investors include GF Securities, BPC Banking Tech, Quark Venture, Triventures, and Rimonci.